Back
Kiniksa Pharmaceuticals International PLC Vs. Biogen Industry Stock Comparison
Sell
41
KNSA
Kiniksa Pharmaceuticals International PLC
Last Price:
21.30
Seasonality Move:
39.39%
Sell
28
BIIB
Biogen
Last Price:
157.84
Seasonality Move:
12.81%
Sell
41
Kiniksa Pharmaceuticals International PLC (KNSA)
is a Sell
Is Kiniksa Pharmaceuticals International PLC a Buy, Sell or Hold?
- The current Kiniksa Pharmaceuticals International PLC [KNSA] share price is $21.28. The Score for KNSA is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- KNSA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Biogen (BIIB)
is a Sell
Is Biogen a Buy, Sell or Hold?
- The current Biogen [BIIB] share price is $157.90. The Score for BIIB is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- BIIB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KNSA Stock Price Chart
What is Kiniksa Pharmaceuticals International PLC's stock price today?
-
The Kiniksa Pharmaceuticals International PLC share price today is $21.28
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KNSA is experiencing slight selling pressure.
BIIB Stock Price Chart
KNSA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1 | Sell |
Relative Strength Index (14 RSI): | 36.27 | Sell |
Chaikin Money Flow: | -19243 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.15 - 25.47) | Sell |
Bollinger Bands (100): | (22.24 - 26.48) | Sell |
BIIB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -7.69 | Sell |
Relative Strength Index (14 RSI): | 24.44 | Sell |
Chaikin Money Flow: | -837030 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (162.16 - 182.18) | Sell |
Bollinger Bands (100): | (177.63 - 215.81) | Sell |
KNSA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.45 | Sell |
20-day SMA: | 22.45 | Sell |
50-day SMA: | 24.26 | Sell |
200-day SMA: | 21.8 | Sell |
8-day EMA: | 21.53 | Sell |
20-day EMA: | 22.5 | Sell |
50-day EMA: | 23.6 | Sell |
200-day EMA: | 22.03 | Sell |
BIIB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 159.49 | Sell |
20-day SMA: | 169.26 | Sell |
50-day SMA: | 181.96 | Sell |
200-day SMA: | 208.06 | Sell |
8-day EMA: | 160.27 | Sell |
20-day EMA: | 167.71 | Sell |
50-day EMA: | 179.71 | Sell |
200-day EMA: | 207.11 | Sell |
Kiniksa Pharmaceuticals International PLC Earnings Growth & KNSA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.19 per share, and an increase next year of $0.89 per share.
Biogen Earnings Growth & BIIB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.32 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.43 per share, and an increase next year of $0.26 per share.
Kiniksa Pharmaceuticals International PLC Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Biogen Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |